Invention Grant
US08642565B2 Increase of immune response and targeting by antigens and/or drug linkage
有权
通过抗原和/或药物连接增加免疫应答和靶向
- Patent Title: Increase of immune response and targeting by antigens and/or drug linkage
- Patent Title (中): 通过抗原和/或药物连接增加免疫应答和靶向
-
Application No.: US12741980Application Date: 2008-11-07
-
Publication No.: US08642565B2Publication Date: 2014-02-04
- Inventor: Vincent Serra
- Applicant: Vincent Serra
- Applicant Address: FR Reims
- Assignee: Wittycell
- Current Assignee: Wittycell
- Current Assignee Address: FR Reims
- Agency: Merchant & Gould P.C.
- Priority: EP07291336 20071107
- International Application: PCT/EP2008/065179 WO 20081107
- International Announcement: WO2009/060086 WO 20090514
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K38/17 ; C07H15/04
Abstract:
The present invention relates to compounds consisting of glycolipids covalently bound to an antigen or a drug via a linker. The said compounds are able to induce a stronger immune response than a composition comprising separated glycolipids and antigen. The said compounds are also able to target drug to CD1d restricted cells.
Public/Granted literature
- US20100330111A1 INCREASE OF IMMUNE RESPONSE AND TARGETING BY ANTIGENS AND/OR DRUG LINKAGE Public/Granted day:2010-12-30
Information query
